Medpace Holdings, Inc.MEDP
NasdaqGS•Healthcare•Diagnostics & Research
Understand cash generation quality and how management allocates capital.
Free cash flow was $144.97M in the latest quarter (25.1% increase YoY). FCF margin is 5.4%. Shares outstanding declined by 6.4% year-over-year, indicating buybacks (returning capital to shareholders). Free cash flow is the lifeblood of a business — it funds dividends, buybacks, debt reduction, and reinvestment without relying on external capital.
Free cash flow, earnings quality, and capital allocation